Analysis of 160 nonhospitalized COVID-19 patients with mild to moderate symptoms from an Austrian general medical practice: from typical disease pattern to unexpected clinical featuresObservational Study Published on 2022-06-012022-10-04 Journal: Wiener medizinische Wochenschrift (1946) [Category] COVID19(2023년), SARS, 임상, [키워드] Abnormal blood texture acute respiratory syndrome Blood Chest clinical feature Clinical features confirmed cases coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 patient COVID-19 symptoms develop disease disorder English fatigue Hormonal changes Infection joint joints laboratory-confirmed Long Long COVID Mild moderate Pain pandemic Participants participated pathophysiology Patient patients PCR polymerase chain Post COVID-19 joints. Praxis real-world data SARS-CoV-2 Serological testing Shortness of breath skeletal muscles sore throat suspected patient Symptom Symptoms tension therapeutic approaches virus infection [DOI] 10.1007/s10354-022-00919-0 PMC 바로가기 [Article Type] Observational Study
Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCRRT-PCR을 사용한 염증 마커를 평가함으로써 COVID-19 환자에서 카 다몬 추출물의 항 염증 반응 및 치료 창의 예측Article Published on 2022-06-012022-08-31 Journal: Inflammopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료제, [키워드] addition alternative Anti-inflammatory anti-inflammatory action anti-inflammatory response Anti-viral association attending physician Awareness breathlessness can not Cardamom Clinical improvement Clinical practice clinician control group cough Course COVID-19 COVID-19 patient COVID-19 patients COVID-19 symptom COVID-19 symptoms CRP Ct values cycle threshold cytokine Cytokine storm dawn Diagnostic method diagnostic test diagnostic tests disease Disease progression dosage dose effective elevated end point enrolled Fever FORTE gene expression profile hospital IL-10 IL-6 India indicate Inflammation Inflammatory marker inflammatory markers inflammatory parameter intake Intervention lack LDH majority material molecular diagnostics morbidity morbidity and mortality multiplex negativity normalized onset of symptom outcome parameter Patient patients PCR test performed popularity potentiality predict Prednisolone prevalent Prognosis protein level provide reason for reducing reported RT-PCR RT-PCR analysis RT-PCR assay RT-PCR test SARS-CoV-2 SARS-CoV-2 RT-PCR SARS-CoV-2 RT-PCR test serum Serum IL-6 sore throat Standard of care standard treatment Steroids Symptom Tablet tested the cytokine storm the patient therapeutic window time TNF- α Treatment treatment arm treatment group were given worsening [DOI] 10.1007/s10787-022-00951-x PMC 바로가기 [Article Type] Article
Online symptoms self-assessment during COVID-19 pandemic: an analysis of a COVID-19 portal responses from Canada Research Published on 2022-05-312022-10-05 Journal: Scientific Reports [Category] 치료기술, [키워드] Analysis analyzed Canada Care China Community conducted confirmed case confirmed COVID-19 case correlation cough COVID COVID-19 COVID-19 case COVID-19 cases COVID-19 illness COVID-19 pandemic Descriptive statistics digestive distribution evaluate fatigue First wave FIVE Guidance headache Health Health Service Heath individual pandemic peak primary care problem provided Public Record reducing reported reported symptom response sore throat Symptom Symptoms the WHO Toronto trend utility viral infection Volume were recorded were used West Wuhan [DOI] 10.1038/s41598-022-13053-z [Article Type] Research
Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases알레르기 질환 환자에서 비활성화된 SARS-CoV-2 백신의 안전성Clinical Trial Published on 2022-05-272022-09-12 Journal: Respiratory Research [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] Administered administration affecting allergic allergic disease allergic diseases anti-SARS-CoV-2 IgG Chinese clinical control group diarrhea disease dose event fatigue first dose Frequency General population Hospitalized immunogenicity inactivated incidence injection Local local reaction occurred less Occurrence participant Participants Patient positive IgG antibodies Prevalence reactive registry reported retrospective cohort study Safe Safety SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Serious Adverse Event Seven skin rash sore throat subjects systemic reaction systemic reactions the patient vaccination Vaccine vertigo [DOI] 10.1186/s12931-022-02054-1 PMC 바로가기 [Article Type] Clinical Trial
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study도시 이란 인구에서 SARS-CoV-2 항체의 혈청 유병률: 두 번째 대규모 인구 기반 단면 연구의 결과Article Published on 2022-05-232022-09-12 Journal: BMC Public Health [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI adjusted Anosmia arthralgia asked Asymptomatic chest pain chills conducted cough COVID-19 COVID-19 infection COVID-19-related symptoms cross-sectional diarrhea Dyspnea ELISA kits Fever First wave General population headache Health healthcare highest IgM antibody individual infected individual infected individuals Infection Iran lowest myalgia National participant Presence Randomly Registered SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2-specific IgG seropositive individual Seroprevalence Serosurvey sore throat Symptom Tabriz the disease the epidemic the SARS-CoV-2 weakness Weighting [DOI] 10.1186/s12889-022-13464-7 PMC 바로가기 [Article Type] Article
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-191차 진료 또는 병원 외래 환자 환경에 있는 환자가 COVID-19에 감염되었는지 확인하기 위한 징후 및 증상Review Published on 2022-05-202022-09-11 Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] 95% CI absence Abstract Accuracy addition Adults age Ageusia Analysis Anosmia applicability artificial intelligence assessment assessments Bern Chain Reaction characteristic checked children clinically clinically suspected clinics Cohort Combination combinations condition Consequences Contact Control coryza cough COVID-19 COVID-19 disease COVID-19 illness COVID-19 pneumonia COVID-19 testing criteria criterion Data collection database dependent on detection rate determine determined by diagnostic Diagnostic accuracy diagnostic test diagnostic tests diagnostic value disease Dyspnoea eligibility eligible emergency department enrolled Evidence excluded fatigue Fever FIVE Gender Health Service Health services help heterogeneity high risk hospital identify increase individual individual symptom Infection Infectious disease information initial investigated life-threatening likelihood ratio Local loss of sense of smell majority mechanism median Meta-analysis Mild Mild COVID-19 disease moderate MOST multivariable no symptom no symptoms nursing homes Older olfactory on children Outpatient outpatients overlapping pair parameter participant Participants Patient PCR Pneumonia polymerase chain polymerase chain reaction positive Presence presenting primary care Probability Prognosis Prospective Study QUADAS-2 random-effect reached receiver operating characteristic recruited reference standard Reference standards referred to reported Repository resolved Result reverse transcription reverse transcription polymerase chain reaction risk of bia ROC RT-PCR Sample size SARS-COV-2 infection selected Selection sense sense of smell sensitivity Sensitivity and specificity SIGN Signs and symptoms sore sore throat specific symptom Specificities specificity Support Symptom Symptoms Taste the disease the epidemic Travel treated University of Bern upper respiratory symptom upper respiratory symptoms were measured with COVID-19 [DOI] 10.1002/14651858.CD013665.pub3 PMC 바로가기 [Article Type] Review
Clinical Presentation and Outcome of Hospitalized Patients With COVID-19 in the First and Second Waves in Saudi Arabia사우디 아라비아의 1차 및 2차 유행에서 COVID-19로 입원한 환자의 임상 발표 및 결과Article Published on 2022-05-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] age ALT Antibiotics antiviral therapy case sery Characteristics clinical Clinical characteristics Clinical data COVID-19 death death rate distress epidemiological First wave hospitalized patient hospitalized patients Laboratory lymphocyte Lymphocytes mean value myalgia Occurrence outcome Patient Platelet platelet counts presentation receive respiratory distress retrospective SARS-CoV-2 Saudi Arabia second second wave Shortness of breath significantly significantly more sore sore throat Symptoms tachypnea the SARS-CoV-2 variants Wave Waves [DOI] 10.1016/j.ijid.2022.02.048 PMC 바로가기 [Article Type] Article
The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trialRandomized Controlled Trial Published on 2022-05-012022-10-05 Journal: Complementary therapies in medicine [Category] COVID19(2023년), SARS, 임상, [키워드] Affect Arm assigned baseline Biomarker C-reactive protein test chain changes in Characteristics chill Clinical outcome Clinical sign Clinical symptoms clinical variable control arm Controlled trial cough COVID-19 COVID-19 patients CRP levels CT scans demographics diagnostic double-blind Effect eight evaluate the effect evaluated Fever hospital increase in Intervention intervention arm Laboratory LOS lung involvement marker myalgia not significant not significantly different organic oxygen saturation Patient Phyllanthus Phyllanthus Emblica Phyllanthus Emblica. Randomized Randomly RCT reaction reduction in respiratory rate RT-PCR severity Shortness of breath significantly significantly shorter sore throat SpO2 study group Symptom the mean therapy two group variable variables weakness were assessed [DOI] 10.1016/j.ctim.2022.102808 PMC 바로가기 [Article Type] Randomized Controlled Trial
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study오미크론 및 델타 변이가 우세한 기간 동안 SARS-CoV-2에 감염된 개인의 증상 유병률, 기간 및 입원 위험: ZOE COVID 연구의 전향적 관찰 연구Observational Study Published on 2022-04-232022-09-11 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] 1:1 95% CI age appear body-mass body-mass index chronic chronic disease collected data COVID dose Eligible participants foundation Hospital admission individual infected with SARS-CoV-2 Infection infectiousness lateral flow result less likelihood Loss Loss of Smell Lower respiratory tract Medical Research Council observational study Odds ratio omicron participant Patient PCR positive Positive test Prevalence prevalent Primary outcome Probability prospective observational study public health reduced reported symptom reported symptoms risk SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant Sex sore sore throat study period Symptom symptom duration symptomatic tested vaccination variant Wellcome Trust [DOI] 10.1016/S0140-6736(22)00327-0 PMC 바로가기 [Article Type] Observational Study
Whole Exome Sequencing Identifies a Rare Mutation in NACAD as a Possible Cause of COVID orchitis in BrothersConference abstract Published on 2022-04-012022-10-05 Journal: The journal of sexual medicine [Category] 변종, [키워드] ACE2 ACE2 pathway Affect affected age amino acid change antigens average Blood body aches Brother cause cellular cellular entry chromosome 7 circulating controls cough COVID COVID-19 COVID-19 patient Critical current Cytokine storm DNA extraction Evidence examined Exome Extracellular Fever FIVE frameshift Frequency Genetic genetic susceptibility Genotype Human hypothese IgG Inflammation involved kidneys less liver Lungs men Mutation NACAD nonsynonymous objective organ Pain pathogenicity Patient patients PCR PCR positive performed plasma samples polymerase chain population prevalence Prevalence PROTECT R&D Systems report Result SARS CoV-2 SARS-CoV2 Sequencing Serum level soluble ACE2 sore throat subject susceptibility Symptom syndrome testicular pain Transport USA variant variants Vascular endothelium WES while with COVID-19 [DOI] 10.1016/j.jsxm.2022.01.068 [Article Type] Conference abstract